Washington, DC - A secondary analysis of the Hemodialysis (HEMO) Study highlights the significant biases in trial results that can occur when as-treated vs intention-to-treat methodology is applied [ ...
Most bacteria possess only one heme-degrading enzyme for obtaining iron, however few bacteria such as Pseudomonas aeruginosa express two, namely PhuS and HemO. While HemO is a well-known heme ...
LONDON, UK / ACCESSWIRE / July 10, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the Company ...
LONDON, UK / ACCESSWIRE / November 18, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for deadly blood diseases, is pleased to ...
LONDON, UK / ACCESSWIRE / May 9, 2023 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) ("Hemogenyx Pharmaceuticals" or the "Company"), the biopharmaceutical group developing new therapies and treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results